Skip to content
HowShorted

Damora Therapeutics, Inc. short interest in 2024

In 2024, Damora Therapeutics, Inc.'s disclosed short interest ran from 0.52% of shares outstanding on 12 Jan 2024 to 1.27% on 31 Dec 2024, a change of +0.75 percentage points. The year's high was 1.84% on 13 Dec 2024 and its low 0.03% on 15 Aug 2024, averaging 0.51% across 15 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.28 days on 13 Dec 2024. Full history: Damora Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Damora Therapeutics, Inc. in 2024

2024 in figures

Start of year
0.52% (12 Jan 2024)
End of year
1.27% (31 Dec 2024)
Change
+0.75 pp
High
1.84% (13 Dec 2024)
Low
0.03% (15 Aug 2024)
Average
0.51%
Highest days to cover
1.28 (13 Dec 2024)
SEC filings marked
4

Every report in 2024

Damora Therapeutics, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20240.52%1.00
31 Jan 20240.24%1.00
15 Feb 20240.14%1.00
29 Feb 20240.20%1.00
28 Mar 20240.12%1.0010-K filed
15 Apr 20240.07%1.00
30 Apr 20240.31%1.0710-Q filed
15 May 20240.17%1.00
28 Jun 20240.11%1.00
15 Aug 20240.03%1.0010-Q filed
31 Oct 20240.36%1.00
15 Nov 20240.72%1.0010-Q filed
29 Nov 20241.53%1.03
13 Dec 20241.84%1.28
31 Dec 20241.27%1.00

See also: Damora Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.